The efficacy of eszopiclone (Lunesta) for Chronic insomnia associated with osteoarthritis
Phase of Trial: Phase III
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Eszopiclone (Primary)
- Indications Insomnia; Pain
- Focus Therapeutic Use
- 07 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Jun 2013 Planned end date changed from 1 Jan 2008 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 23 Oct 2006 The expected completion date for this trial is now 1 Jan 2008.